UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000046841
Receipt No. R000053441
Scientific Title Multi-omics cohort analysis and biobank construction in Japanese patients with inflammatory bowel disease
Date of disclosure of the study information 2022/03/31
Last modified on 2022/04/20 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Multi-omics cohort analysis and biobank construction in Japanese patients with inflammatory bowel disease
Acronym IBD-MOCHA
Scientific Title Multi-omics cohort analysis and biobank construction in Japanese patients with inflammatory bowel disease
Scientific Title:Acronym IBD-MOCHA
Region
Japan

Condition
Condition Inflammatory bowel disease
Crohn's disease
Ulcerative Colitis
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 Factors involved in the development and prognosis of inflammatory bowel disease
Basic objectives2 Others
Basic objectives -Others Omics analysis to search for factors involved in the above and construction of a biobank of specimens for this purpose.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Genetic factors involved in pathogenesis
Key secondary outcomes Serum proteins, gut microbiota, and genetic background related to prognosis and pathology

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Inflammatory bowel disease (Crohn's disease, ulcerative colitis, unclassifiable enteritis) or suspected cases
Key exclusion criteria Cases in which the cause of enteritis symptoms is obvious (infectious enteritis, ischemic enteritis, diverticulitis, etc.)

Other cases that the attending physician considers inappropriate
Target sample size 5500

Research contact person
Name of lead principal investigator
1st name Yoichi
Middle name
Last name Kakuta
Organization Tohoku University Hospital
Division name Division of Gastroenterology
Zip code 980-8574
Address 1-1 Seiryo Aoba, Sendai
TEL 0227177171
Email ykakuta@med.tohoku.ac.jp

Public contact
Name of contact person
1st name Yoichi
Middle name
Last name Kakuta
Organization Tohoku University Hospital
Division name Division of Gastroenterology
Zip code 980-8574
Address 1-1 Seiryo Aoba, Sendai
TEL 0227177171
Homepage URL
Email ykakuta@med.tohoku.ac.jp

Sponsor
Institute Tohoku University
Institute
Department

Funding Source
Organization Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tohoku University Graduate School of Medicine Ethics Committee
Address 1-1 Seiryo Aoba, Sendai
Tel 022-728-4105
Email med-kenkyo@grp.tohoku.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2022 Year 03 Month 28 Day
Date of IRB
2022 Year 03 Month 30 Day
Anticipated trial start date
2022 Year 03 Month 31 Day
Last follow-up date
2027 Year 02 Month 28 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Course of treatment, medical history, etc.

Management information
Registered date
2022 Year 02 Month 06 Day
Last modified on
2022 Year 04 Month 20 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053441